Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis

Livers with parenchymal abnormalities tolerate ischaemia–reperfusion (IR) injury poorly. IR injury is a risk factor for hepatocellular carcinoma (HCC) recurrence. This study assessed the link between liver parenchymal abnormalities and HCC recurrence, and evaluated the protective effect of ischaemic preconditioning.

[1]  P. Morel,et al.  Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation , 2015, The British journal of surgery.

[2]  O. Rotstein,et al.  Remote Ischemic Conditioning Prevents Lung and Liver Injury After Hemorrhagic Shock/Resuscitation: Potential Role of a Humoral Plasma Factor. , 2015, Annals of surgery.

[3]  J. Lee,et al.  Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma. , 2015, Gastroenterology.

[4]  M. Abouljoud,et al.  Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation , 2015, Hepatology.

[5]  J. Vallée,et al.  Pre-retrieval reperfusion decreases cancer recurrence after rat ischemic liver graft transplantation. , 2014, Journal of hepatology.

[6]  P. Bie,et al.  Different roles of hepatic hypothermic ischemia and ischemic preconditioning in chemically induced hepatocarcinogenesis in rats. , 2014, The Journal of surgical research.

[7]  P. Morel,et al.  The Role of Hepatic Ischemia–Reperfusion Injury and Liver Parenchymal Quality on Cancer Recurrence , 2014, Digestive Diseases and Sciences.

[8]  L. Rubbia‐Brandt,et al.  Alloimmune Activation Promotes Anti-Cancer Cytotoxicity after Rat Liver Transplantation , 2014, PloS one.

[9]  A. Diehl,et al.  NAFLD, NASH and liver cancer , 2013, Nature Reviews Gastroenterology &Hepatology.

[10]  N. Chandok,et al.  Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  D. Samuel,et al.  Resection or Transplantation for Early Hepatocellular Carcinoma in a Cirrhotic Liver: Does Size Define the Best Oncological Strategy? , 2012, Annals of surgery.

[12]  M. Yarmush,et al.  Liver Defatting: An Alternative Approach to Enable Steatotic Liver Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  F. Roudot-thoraval,et al.  Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. , 2012, Gastroenterology.

[14]  W. Lau,et al.  Selective main portal vein clamping to minimize the risk of recurrence after curative liver resection for hepatocellular carcinoma. , 2012, Hepato-gastroenterology.

[15]  R. Wiesner,et al.  Treatment of recurrent hepatocellular carcinoma after liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[16]  J. Feinglass,et al.  A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. , 2011, Journal of hepatology.

[17]  C. Brenner,et al.  Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes , 2011, Cell Death and Disease.

[18]  I. B. Borel Rinkes,et al.  Prolonged portal triad clamping during liver surgery for colorectal liver metastases is associated with decreased time to hepatic tumour recurrence. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  J. Llovet,et al.  A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. , 2009, Gastroenterology.

[20]  A. M. Shapiro,et al.  Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database , 2009, Hepatology.

[21]  S. Fan,et al.  Ischemia‐reperfusion of small liver remnant promotes liver tumor growth and metastases—Activation of cell invasion and migration pathways , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[22]  W. Jochum,et al.  Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. , 2006, Journal of hepatology.

[23]  K. Chijiiwa,et al.  Prognostic benefit of selective portal vein occlusion during hepatic resection for hepatocellular carcinoma. , 2005, Surgery.

[24]  P. V. van Diest,et al.  Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model , 2005, Hepatology.

[25]  W. Jochum,et al.  Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism. , 2003, Journal of Hepatology.

[26]  J. Roselló-Catafau,et al.  Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. , 2002, The American journal of pathology.

[27]  Kuniyoshi Tanaka,et al.  Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. , 2002, The Journal of surgical research.

[28]  O. Farges,et al.  Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. , 2000, Journal of the American College of Surgeons.

[29]  M. Stegall,et al.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.

[30]  M. Dumont,et al.  European Association for the Study of the Liver , 1971 .

[31]  V. Mazzaferro,et al.  EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer , 2012 .

[32]  N. L. Johnson,et al.  Multivariate Analysis , 1958, Nature.